6 Conclusions
6.4 Future research for BPH surgery
Our data showed the clinical efficacy after BPH surgeries, postoperative 6 months to 3 years (early to medium follow-up). The long -term follow-up (more than 3 years) for these surgical methods is unclear. Regarding enucleation methods, there are many different surgical techniques in enucleation surgery such as upside down, apical preservation methods, vapo-enucleation methods etc. It is not known whether the results for these methods are all the same. Short-term transient urinary incontinence and steep learning curve are two problems hindering the popularity of enucleation surgery. It is unclear, how to decrease the incidence of short-term transient incontinence and shorten the learning curve for enucleation methods. Regarding vaporization methods, a higher energy system is evolving; the efficacy and efficiency of the higher energy system needs further research.
References
1. Rassweiler J, Rassweiler MC, Kenngott H, Frede T, Michel MS, Alken P, et al. The past, present and future of minimally invasive therapy in urology: a review and speculative outlook. Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy 2013;22(4):200-9.
2. Ministry of health and wealfare. Main surgical treatment statistics [Available from:
accessed Dec 31, 2018.
3. Chaussy C, Brendel W, Schmiedt E. Extracorporeally induced destruction of kidney stones by shock waves. Lancet (London, England) 1980;2(8207):1265-8.
4. McAteer JA, Evan AP. The acute and long-term adverse effects of shock wave lithotripsy. Seminars in nephrology 2008;28(2):200-13.
5. Willis LR, Evan AP, Connors BA, Blomgren P, Fineberg NS, Lingeman JE.
Relationship between kidney size, renal injury, and renal impairment induced by shock wave lithotripsy. Journal of the American Society of Nephrology : JASN 1999;10(8):1753-62.
6. Connors BA, Evan AP, Willis LR, Blomgren PM, Lingeman JE, Fineberg NS. The effect of discharge voltage on renal injury and impairment caused by lithotripsy in the pig. Journal of the American Society of Nephrology : JASN
2000;11(2):310-8.
7. Kaude JV, Williams CM, Millner MR, Scott KN, Finlayson B. Renal morphology and function immediately after extracorporeal shock-wave lithotripsy. AJR Am J Roentgenol 1985;145(2):305-13.
8. Krishnamurthi V, Streem SB. Long-term radiographic and functional outcome of extracorporeal shock wave lithotripsy induced perirenal hematomas. The Journal of urology 1995;154(5):1673-5.
9. Baskin LS, Stoller ML. Severe haemorrhage after extracorporeal shock wave lithotripsy: radiological evaluation. Br J Urol 1992;69(2):214-5.
10. Treglia A, Moscoloni M. Irreversible acute renal failure after bilateral extracorporeal shock wave lithotripsy. J Nephrol 1999;12(3):190-2.
11. Abate N, Chandalia M, Cabo-Chan AV, Jr., Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 2004;65(2):386-92.
12. Cupisti A, D'Alessandro C, Samoni S, Meola M, Egidi MF. Nephrolithiasis and hypertension: possible links and clinical implications. J Nephrol
2014;27(5):477-82.
13. Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Samuel S, Klarenbach SW, et al.
Kidney stones and cardiovascular events: a cohort study. Clinical journal of the American Society of Nephrology : CJASN 2014;9(3):506-12.
14. Handa RK, Liu Z, Connors BA, Alloosh M, Basile DP, Tune JD, et al. Effect of renal shock wave lithotripsy on the development of metabolic syndrome in a juvenile swine model: a pilot study. The Journal of urology
2015;193(4):1409-16.
15. Claro Jde A, Lima ML, Ferreira U, Rodrigues Netto N, Jr. Blood pressure changes
after extracorporeal shock wave lithotripsy in normotensive patients. The Journal of urology 1993;150(6):1765-7.
16. Zanetti GR, Montanari E, Guarneri A, Trinchieri A, Mandressi A, Ceresoli A.
Long-term followup after extracorporeal shock wave lithotripsy treatment of kidney stones in solitary kidneys. The Journal of urology 1992;148(3 Pt 2):1011-4.
17. Krambeck AE, Gettman MT, Rohlinger AL, Lohse CM, Patterson DE, Segura JW.
Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of followup. The Journal of urology 2006;175(5):1742-7.
18. de Cogain M, Krambeck AE, Rule AD, Li X, Bergstralh EJ, Gettman MT, et al.
Shock wave lithotripsy and diabetes mellitus: a population-based cohort study.
Urology 2012;79(2):298-302.
19. Sato Y, Tanda H, Kato S, Ohnishi S, Nakajima H, Nanbu A, et al. Shock wave lithotripsy for renal stones is not associated with hypertension and diabetes mellitus. Urology 2008;71(4):586-91; discussion 91-2.
20. Protogerou V, Deliveliotis C, Protogerou A, Kotsis V, Karayiannis V, Zakopoulos N, et al. Extracorporeal shockwave lithotripsy for kidney stones reduces blood pressure: use of 24-hour ambulatory monitoring for study of blood-pressure changes induced by SWL. J Endourol 2004;18(1):17-22.
21. Jewett MA, Bombardier C, Logan AG, Psihramis KE, Wesley-James T, Mahoney JE, et al. A randomized controlled trial to assess the incidence of new onset
hypertension in patients after shock wave lithotripsy for asymptomatic renal calculi. The Journal of urology 1998;160(4):1241-3.
22. Elves AW, Tilling K, Menezes P, Wills M, Rao PN, Feneley RC. Early observations of the effect of extracorporeal shockwave lithotripsy on blood pressure: a prospective randomized control clinical trial. BJU international
2000;85(6):611-5.
23. Krambeck AE, Rule AD, Li X, Bergstralh EJ, Gettman MT, Lieske JC. Shock wave lithotripsy is not predictive of hypertension among community stone formers at long-term followup. The Journal of urology 2011;185(1):164-9.
24. Denburg MR, Jemielita TO, Tasian GE, Haynes K, Mucksavage P, Shults J, et al.
Assessing the risk of incident hypertension and chronic kidney disease after exposure to shockwave lithotripsy and ureteroscopy. Kidney Int 2015 25. Chapple CR. Lower urinary tract symptoms suggestive of benign prostatic
obstruction--Triumph: design and implementation. Eur Urol 2001;39 Suppl 3:31-6.
26. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. The Journal of urology 1993;150(1):85-9.
27. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. The Journal of urology 2005;173(4):1256-61.
28. Kirby RS. The natural history of benign prostatic hyperplasia: what have we learned in the last decade? Urology 2000;56(5 Suppl 1):3-6.
29. Reich O, Seitz M, Gratzke C, Schlenker B, Walther S, Stief C. [Benign prostatic
hyperplasia (BPH) : Surgical therapy options]. Der Urologe Ausg A 2010;49(1):113-26.
30. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, et al.
Morbidity, mortality and early outcome of transurethral resection of the prostate:
a prospective multicenter evaluation of 10,654 patients. The Journal of urology 2008;180(1):246-9.
31. Hoffman RM, MacDonald R, Monga M, Wilt TJ. Transurethral microwave
thermotherapy vs transurethral resection for treating benign prostatic hyperplasia:
a systematic review. BJU international 2004;94(7):1031-6.
32. Schulman CC, Zlotta AR, Rasor JS, Hourriez L, Noel JC, Edwards SD.
Transurethral needle ablation (TUNA): safety, feasibility, and tolerance of a new office procedure for treatment of benign prostatic hyperplasia. Eur Urol
1993;24(3):415-23.
33. Thalmann GN, Graber SF, Bitton A, Burkhard FC, Gruenig O, Studer UE.
Transurethral thermotherapy for benign prostatic hyperplasia significantly decreases infravesical obstruction: results in 134 patients after 1 year. The Journal of urology 1999;162(2):387-93.
34. Bouza C, Lopez T, Magro A, Navalpotro L, Amate JM. Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia. BMC Urol 2006;6:14.
35. Kim ED. Ethanol injection for the treatment of benign prostatic hyperplasia. Current urology reports 2002;3(4):276-9.
36. Muschter R, Whitfield H. Interstitial laser therapy of benign prostatic hyperplasia.
Eur Urol 1999;35(2):147-54.
37. Lourenco T, Pickard R, Vale L, Grant A, Fraser C, MacLennan G, et al. Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials. BMJ (Clinical research ed) 2008;337:a1662.
38. Fraundorfer MR, Gilling PJ. Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 1998;33(1):69-72.
39. Lusuardi L, Mitterberger M, Hruby S, Kunit T, Kloss B, Engelhardt PF, et al.
Update on the use of diode laser in the management of benign prostate obstruction in 2014. World journal of urology 2015;33(4):555-62.
40. Xia SJ. Two-micron (thulium) laser resection of the prostate-tangerine technique: a new method for BPH treatment. Asian journal of andrology 2009;11(3):277-81.
41. Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, et al.
Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 2010;58(3):384-97.
42. Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, et al. EAU Guidelines on the Assessment of Non-neurogenic Male Lower
Urinary Tract Symptoms including Benign Prostatic Obstruction. Eur Urol 2015;67(6):1099-109.
43. Tang Y, Li J, Pu C, Bai Y, Yuan H, Wei Q, et al. Bipolar transurethral resection versus monopolar transurethral resection for benign prostatic hypertrophy: a
systematic review and meta-analysis. J Endourol 2014;28(9):1107-14.
44. Yin L, Teng J, Huang CJ, Zhang X, Xu D. Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and
meta-analysis of randomized controlled trials. J Endourol 2013;27(5):604-11.
45. Zhang X, Geng J, Zheng J, Peng B, Che J, Liang C. Photoselective vaporization versus transurethral resection of the prostate for benign prostatic hyperplasia: a meta-analysis. J Endourol 2012;26(9):1109-17.
46. Evidence-based medicine. A new approach to teaching the practice of medicine.
Jama 1992;268(17):2420-5.
47. Lee YH, Huang WC, Tsai JY, Lu CM, Chen WC, Lee MH, et al. Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urologia
internationalis 2002;68(3):172-7.
48. Health Do. National Health Insurance Annual Statistical Report [
49. Apple d. 77,000 patients received SWL last year [updated Oct 31,2016. accessed April 01,2017.
50. Sutton AJ, Higgins JP. Recent developments in meta-analysis. Statistics in medicine 2008;27(5):625-50.
51. Ades AE, Sculpher M, Sutton A, Abrams K, Cooper N, Welton N, et al. Bayesian methods for evidence synthesis in cost-effectiveness analysis.
PharmacoEconomics 2006;24(1):1-19.
52. Song F, Loke YK, Walsh T, Glenny AM, Eastwood AJ, Altman DG. Methodological problems in the use of indirect comparisons for evaluating healthcare
interventions: survey of published systematic reviews. BMJ (Clinical research ed) 2009;338:b1147.
53. Song F, Xiong T, Parekh-Bhurke S, Loke YK, Sutton AJ, Eastwood AJ, et al.
Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ (Clinical research ed) 2011;343:d4909.
54. National Health Insurance Research Database, National Helath Research Institutes 2014 accessed Jan 01, 2017.
55. Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. Journal of clinical epidemiology
1992;45(7):769-73.
56. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration; 2011 [updated March 2011], version 5.1.0.
57. White IR. Network meta-analysis. Stata J 2015:15:951e85.
58. Lu GB, Ades AE. Assessing evidence inconsistency in mixed treatment comparisons.
J Am Stat Assoc:2006;101:447e59.
59. White IR, Barrett JK, Jackson D, Higgins JP. Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression.
Research synthesis methods 2012;3(2):111-25.
60. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. Journal of clinical epidemiology 2011;64(2):163-71.
61. Mamoulakis C, Efthimiou I, Kazoulis S, Christoulakis I, Sofras F. The modified
Clavien classification system: a standardized platform for reporting
complications in transurethral resection of the prostate. World journal of urology 2011;29(2):205-10.
62. Barbosa PV, Makhlouf AA, Thorner D, Ugarte R, Monga M. Shock wave lithotripsy associated with greater prevalence of hypertension. Urology 2011;78(1):22-5.
63. Cappuccio FP, Strazzullo P, Mancini M. Kidney stones and hypertension: population based study of an independent clinical association. BMJ (Clinical research ed) 1990;300(6734):1234-6.
64. Madore F, Stampfer MJ, Willett WC, Speizer FE, Curhan GC. Nephrolithiasis and risk of hypertension in women. Am J Kidney Dis 1998;32(5):802-7.
65. Engel WJ, Page IH. Hypertension due to renal compression resulting from subcapsular hematoma. The Journal of urology 1955;73(5):735-9.
66. Lingeman JE, Woods JR, Toth PD. Blood pressure changes following extracorporeal shock wave lithotripsy and other forms of treatment for nephrolithiasis. Jama 1990;263(13):1789-94.
67. Carr LK, J DAH, Jewett MA, Ibanez D, Ryan M, Bombardier C. New stone formation: a comparison of extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy. The Journal of urology 1996;155(5):1565-7.
68. Hassan I, Zietlow SP. Acute pancreatitis after extracorporeal shock wave lithotripsy for a renal calculus. Urology 2002;60(6):1111.
69. Tandan M, Talukdar R, Reddy DN. Management of Pancreatic Calculi: An Update.
Gut and liver 2016;10(6):873-80.
70. National Health Insurance A. Uorlogy reimbursement precaution
71. Besiroglu H, Otunctemur A, Ozbek E. The metabolic syndrome and urolithiasis: a systematic review and meta-analysis. Renal failure 2015;37(1):1-6.
72. Marchini GS, Sarkissian C, Tian D, Gebreselassie S, Monga M. Gout, stone composition and urinary stone risk: a matched case comparative study. The Journal of urology 2013;189(4):1334-9.
73. Vela-Navarrete R, Gonzalez-Enguita C, Garcia-Cardoso JV, Manzarbeitia F, Sarasa-Corral JL, Granizo JJ. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002). BJU international 2005;96(7):1045-8.
74. Choi SY, Kim TH, Myung SC, Moon YT, Kim KD, Kim YS, et al. Impact of changing trends in medical therapy on surgery for benign prostatic hyperplasia over two decades. Korean J Urol 2012;53(1):23-8.
75. Stroup SP, Palazzi-Churas K, Kopp RP, Parsons JK. Trends in adverse events of benign prostatic hyperplasia (BPH) in the USA, 1998 to 2008. BJU international 2012;109(1):84-7.
76. Izard J, Nickel JC. Impact of medical therapy on transurethral resection of the prostate: two decades of change. BJU international 2011;108(1):89-93.
77. Flanigan RC, Reda DJ, Wasson JH, Anderson RJ, Abdellatif M, Bruskewitz RC.
5-year outcome of surgical resection and watchful waiting for men with
moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. The Journal of urology 1998;160(1):12-6; discussion 16-7.
78. Kuntz RM, Ahyai S, Lehrich K, Fayad A. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: A randomized prospective trial in 200 patients. Journal of Urology
2004;172(3):1012-16.
79. Ding H, Du W, Lu ZP, Zhai ZX, Wang HZ, Wang ZP. Photoselective green-light laser vaporisation vs. TURP for BPH: meta-analysis. Asian journal of andrology 2012;14(5):720-5.
80. Gallucci M, Puppo P, Perachino M, Fortunato P, Muto G, Breda G, et al.
Transurethral electrovaporization of the prostate vs. transurethral resection.
Results of a multicentric, randomized clinical study on 150 patients. Eur Urol 1998;33(4):359-64.
81. Hoekstra RJ, Van Melick HH, Kok ET, Ruud Bosch JL. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and
electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial. BJU international 2010;106(6):822-6.
82. Chau K, Yee C, Chan C, Chan E, Hou S, Ng C. A prospective randomized controlled trial comparing effi cacy of hybrid bipolar transurethral vaporization and
resection of prostate with bipolar transurethral resection of prostate (TURP).
BJU international 2014; 113.
83. Ben-Zvi T, Hueber PA, Liberman D, Valdivieso R, Zorn KC. GreenLight XPS 180W vs HPS 120W laser therapy for benign prostate hyperplasia: a prospective
comparative analysis after 200 cases in a single-center study. Urology 2013;81(4):853-8.
84. Rai P, Srivastava A, Dhayal IR, Singh S. Comparison of Safety, Efficacy and Cost Effectiveness of Photoselective Vaporization with Bipolar Vaporization of Prostate in Benign Prostatic Hyperplasia. Current urology 2018;11(2):103-09.
85. Abascal JJ, Cecchini RL, Salvador LC, Martos CR, Celma DA, Morote RJ. [Bipolar versus monopolar transurethral resection of the prostate: peroperative analysis of the results]. Actas urologicas españolas 2006; 30(7)..
86. Akcayoz M, Kaygisiz O, Akdemir O, Aki FT, Adsan O, Cetinkaya M. Comparison of transurethral resection and plasmakinetic transurethral resection applications with regard to fluid absorption amounts in benign prostate hyperplasia. Urologia internationalis 2006;77(2):143-7.
87. Akman T, Binbay M, Tekinarslan E, Tepeler A, Akcay M, Ozgor F, et al. Effects of bipolar and monopolar transurethral resection of the prostate on urinary and erectile function: A prospective randomized comparative study. BJU
International 2013; 111(1).
88. Al-Ansari A, Younes N, Sampige VP, Al-Rumaihi K, Ghafouri A, Gul T, et al.
GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: A randomized clinical trial with midterm follow-up. European Urology 2010;58(3):349-55.
89. Al-Rawashdah S, Pastore A, Salhi Y, Fuschi A, Petrozza V, Maurizi A, et al.
Prospective randomized study comparing monopolar with bipolar transurethral resection of prostate in benign prostatic obstruction: 36-month outcomes. World journal of urology 2017; 35(10).
90. Bachmann A, Tubaro A, Barber N, d'Ancona F, Muir G, Witzsch U, et al. A European multicenter randomized noninferiority trial comparing 180 W
GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. The Journal of urology 2015;193(2):570-8.
91. Bachmann A, Tubaro A, Barber N, D'Ancona F, Muir G, Witzsch U, et al. 180-W XPS greenlight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial - The GOLIATH study.
European Urology 2014;65(5):931-42.
92. Thomas JA, Tubaro A, Barber N, d'Ancona F, Muir G, Witzsch U, et al. A
Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study. Eur Urol 2016;69(1):94-102.
93. Basi D, Stankovi J, Poti M, Ignjatovi I, Stojkovi I. Holmium laser enucleation versus transurethral resection of the prostate: a comparison of clinical results.
Acta chirurgica Iugoslavica 2013; 60(1).
94. Bhansali M, Patankar S, Dobhada S, Khaladkar S. Management of large (>60 g) prostate gland: PlasmaKinetic Superpulse (bipolar) versus conventional (monopolar) transurethral resection of the prostate. Journal of Endourology 2009;23(1):141-45.
95. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006;20(8):580-5.
96. Bouchier-Hayes DM, Van Appledorn S, Bugeja P, Crowe H, Challacombe B, Costello AJ. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU International 2010;105(7):964-69.
97. Bozzini G, Seveso M, Melegari S, de Francesco O, Buffi NM, Guazzoni G, et al.
Thulium laser enucleation (ThuLEP) versus transurethral resection of the prostate in saline (TURis): A randomized prospective trial to compare intra and early postoperative outcomes. Actas Urol Esp 2017;41(5):309-15.
98. Capitan C, Blazquez C, Martin MD, Hernandez V, de la Pena E, Llorente C.
GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign
prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol 2011;60(4):734-9.
99. Cetinkaya M, Onem K, Rifaioglu MM, Yalcin V. 980-Nm Diode Laser Vaporization versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia:
Randomized Controlled Study. Urology journal 2015;12(5):2355-61.
100. Chang C, Lin T, Chang Y, Huang W, Lin A, Chen K. Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study. BMC urology 2017; 15..
101. Chen Q, Zhang L, Fan Q, Zhou J, Peng Y, Wang Z. Bipolar transurethral resection
in saline vs traditional monopolar resection of the prostate: results of a randomized trial with a 2-year follow-up. BJU international 2010; 106(9).
102. Chen Q, Zhang L, Liu YJ, Lu JD, Wang GM. Bipolar transurethral resection in saline system versus traditional monopolar resection system in treating large-volume benign prostatic hyperplasia. Urologia internationalis 2009;83(1):55-9.
103. Chen Y, Chen Q, Wang Z, Peng Y, Ma L, Zheng D, et al. A prospective,
randomized clinical trial comparing plasmakinetic resection of the prostate with holmium laser enucleation of the prostate based on a 2-year followup. The Journal of urology 2013; 189(1).
104. Gu M, Chen YB, Liu C, Wan X, Cai ZK, Chen Q, et al. Comparison of Holmium Laser Enucleation and Plasmakinetic Resection of Prostate: A Randomized Trial with 72-Month Follow-Up. Journal of Endourology 2018;32(2):139-43.
105. de Sio M, Autorino R, Quarto G, Damiano R, Perdona S, di Lorenzo G, et al.
Gyrus bipolar versus standard monopolar transurethral resection of the prostate:
a randomized prospective trial. Urology 2006;67(1):69-72.
106. Autorino R, Damiano R, Di Lorenzo G, Quarto G, Perdona S, D'Armiento M, et al.
Four-year outcome of a prospective randomised trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate. Eur Urol 2009;55(4):922-9.
107. Demir A, Karadag MA, Cecen K, Uslu M, Arslan OE. Monopolar versus Plasmakinetic™ Energy Effect on Prostatic Tissue Damage in Terms of PSA Levels: A Prospective Randomized Trial. Urologia Internationalis
2015;95(3):265-68.
108. Demirdag C, Citgez S, Tunc B, Simsekoglu F, Can G, Onal B. The Clinical Effect of Bipolar and Monopolar Transurethral Resection of the Prostate More Than 60 Milliliters. Urology 2017; 98.
109. Dunsmuir WD, McFarlane JP, Tan A, Dowling C, Downie J, Kourambas J, et al.
Gyrus bipolar electrovaporization vs transurethral resection of the prostate: a randomized prospective single-blind trial with 1 y follow-up. Prostate cancer and prostatic diseases 2003;6(2):182-6.
110. Elmansy H, Baazeem A, Kotb A, Badawy H, Riad E, Emran A, et al. Holmium laser enucleation versus photoselective vaporization for prostatic adenoma
greater than 60 ml: preliminary results of a prospective, randomized clinical trial.
The Journal of urology 2012; 188(1).
111. Elsakka AM, Eltatawy HH, Almekaty KH, Ramadan AR, Gameel TA, Farahat Y. A prospective randomised controlled study comparing bipolar plasma vaporisation of the prostate to monopolar transurethral resection of the prostate. Arab Journal of Urology 2016;14(4):280-86.
112. Eltabey M, Sherif H, Hussein A. Holmium laser enucleation versus transurethral resection of the prostate. The Canadian journal of urology 2010; 17(6).
113. Erturhan S, Erbagci A, Seckiner I, Yagci F, Ustun A. Plasmakinetic resection of the prostate versus standard transurethral resection of the prostate: a prospective randomized trial with 1-year follow-up. Prostate cancer and prostatic diseases 2007;10(1):97-100.
114. Fagerström T, Nyman C, Hahn R. Bipolar transurethral resection of the prostate causes less bleeding than the monopolar technique: a single-centre randomized trial of 202 patients. BJU international 2010; 105(11).
115. Fagerström T, Nyman C, Hahn R. Complications and clinical outcome 18 months after bipolar and monopolar transurethral resection of the prostate. Journal of endourology 2011; 25(6).
116. Falahatkar S, Mokhtari G, Moghaddam K, Asadollahzade A, Farzan A, Shahab E, et al.
Bipolar transurethral vaporization: a superior procedure in benign prostatic hyperplasia: a
prospective randomized comparison with bipolar TURP. International braz j urol : official journal of the Brazilian Society of Urology 2014; 40(3).
117. Fayad A, Elsheikh M, Zakaria T, Elfottoh H, Alsergany R, Elshenoufy A, et al.
Holmium Laser Enucleation of the Prostate Versus Bipolar Resection of the Prostate: A Prospective Randomized Study. "Pros and Cons". Urology 2015;
86(5).
118. Fayad A, Sheikh M, Zakaria T, Elfottoh H, Alsergany R. Holmium laser
enucleation versus bipolar resection of the prostate: a prospective randomized study. Which to choose? Journal of endourology 2011; 25(8)..
119. Feng L, Zhang D, Tian Y, Song J. Thulium Laser Enucleation Versus Plasmakinetic
119. Feng L, Zhang D, Tian Y, Song J. Thulium Laser Enucleation Versus Plasmakinetic